Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Victoria Ponce Bobadilla

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Mathematical Medicine and Biology : a Journal of the IMA|March 25, 2017
A stochastic model for tumour control probability that accounts for repair from sublethal damageAna Victoria Ponce Bobadilla, Philip K Maini, Helen Byrne
CPT: Pharmacometrics & Systems Pharmacology|October 16, 2023
Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK modelsDiego Valderrama, Ana Victoria Ponce-Bobadilla, Sven Mensing, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 9, 2025
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's DiseaseSagar S Bachhav, Ana Victoria Ponce-Bobadilla, Diana Clausznitzer, et al.
Clinical and Translational Science|October 28, 2024
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug developmentAna Victoria Ponce-Bobadilla, Vanessa Schmitt, Corinna S Maier, et al.
Bulletin of Mathematical Biology|June 16, 2019
Age Structure Can Account for Delayed Logistic Proliferation of Scratch AssaysAna Victoria Ponce Bobadilla, Thomas Carraro, Helen M Byrne, et al.
Clinical Pharmacokinetics|December 26, 2022
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis PatientsAna Victoria Ponce-Bobadilla, Sven Stodtmann, Doerthe Eckert, et al.
Clinical Pharmacology in Drug Development|July 2, 2024
SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative ColitisSven Stodtmann, Mong-Jen Chen, Ana Victoria Ponce-Bobadilla, et al.
Clinical Pharmacology in Drug Development|July 2, 2024
SERENE ER Analysis Part 1-SERENE CD: Exposure-Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately to Severely Active Crohn DiseaseMong-Jen Chen, Ana Victoria Ponce-Bobadilla, Sven Stodtmann, et al.
Journal of the Royal Society, Interface|April 9, 2019
In vitro cell migration quantification method for scratch assaysAna Victoria Ponce Bobadilla, Jazmine Arévalo, Eduard Sarró, et al.
Clinical Pharmacokinetics|March 11, 2023
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative ColitisAna Victoria Ponce-Bobadilla, Sven Stodtmann, Mong-Jen Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Mathematical Medicine and Biology : a Journal of the IMA|March 25, 2017
A stochastic model for tumour control probability that accounts for repair from sublethal damageAna Victoria Ponce Bobadilla, Philip K Maini, Helen Byrne
CPT: Pharmacometrics & Systems Pharmacology|October 16, 2023
Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK modelsDiego Valderrama, Ana Victoria Ponce-Bobadilla, Sven Mensing, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 9, 2025
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's DiseaseSagar S Bachhav, Ana Victoria Ponce-Bobadilla, Diana Clausznitzer, et al.
Clinical and Translational Science|October 28, 2024
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug developmentAna Victoria Ponce-Bobadilla, Vanessa Schmitt, Corinna S Maier, et al.
Bulletin of Mathematical Biology|June 16, 2019
Age Structure Can Account for Delayed Logistic Proliferation of Scratch AssaysAna Victoria Ponce Bobadilla, Thomas Carraro, Helen M Byrne, et al.
Clinical Pharmacokinetics|December 26, 2022
Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis PatientsAna Victoria Ponce-Bobadilla, Sven Stodtmann, Doerthe Eckert, et al.
Clinical Pharmacology in Drug Development|July 2, 2024
SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative ColitisSven Stodtmann, Mong-Jen Chen, Ana Victoria Ponce-Bobadilla, et al.
Clinical Pharmacology in Drug Development|July 2, 2024
SERENE ER Analysis Part 1-SERENE CD: Exposure-Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients With Moderately to Severely Active Crohn DiseaseMong-Jen Chen, Ana Victoria Ponce-Bobadilla, Sven Stodtmann, et al.
Journal of the Royal Society, Interface|April 9, 2019
In vitro cell migration quantification method for scratch assaysAna Victoria Ponce Bobadilla, Jazmine Arévalo, Eduard Sarró, et al.
Clinical Pharmacokinetics|March 11, 2023
Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative ColitisAna Victoria Ponce-Bobadilla, Sven Stodtmann, Mong-Jen Chen, et al.
Pageof 2